SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001078782-13-000418
Filing Date
2013-03-08
Accepted
2013-03-08 19:39:15
Documents
1
Period of Report
2012-08-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 2068
  Complete submission text file 0001078782-13-000418.txt   3850
Mailing Address 437 S. HWY 101 STE 209 SOLANA BEACH CA 92075
Business Address 437 S. HWY 101 STE 209 SOLANA BEACH CA 92075 858-433-2800
Imprimis Pharmaceuticals, Inc. (Issuer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 9901 S. WILCREST DR. HOUSTON TX 77099
Business Address 9901 S. WILCREST DR. HOUSTON TX 77099 281-933-6948
Professional Compounding Centers of America, Inc. (Reporting) CIK: 0001558044 (see all company filings)

State of Incorp.: TX | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-35814 | Film No.: 13678993